Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2015 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to identify the factors that contribute to placebo response and remission rates in induction and maintenance trials of UC in which patients with active or quiescent disease were enrolled using the UCDAI.

Original publication

DOI

10.1002/14651858.CD011572

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

09/03/2015

Volume

2015